Studies Show Bimekizumab Benefits Patients With Hidradenitis Suppurativa
The BE HEARD I and BE HEARD II studies included more than 1000 adults with moderate to severe hidradenitis suppurativa.
Diagnosis & Disease Information
Adalimumab Efficacious Adjunct to Surgery for Hidradenitis Suppurativa
Risk for postoperative wound infection, complications, hemorrhage no greater with adalimumab versus placebo in hidradenitis suppurativa
Risk for Long-Term Opioid Use Up in Hidradenitis Suppurativa
Odds higher for HS patients with advancing age, ever smoking, history of depression, comorbidity
Guidelines Issued for Managing Hidradenitis Suppurativa
Two-part guideline addresses diagnosis, evaluation, management of the chronic inflammatory skin disease
Bermekimab Looks Promising for Hidradenitis Suppurativa
This investigational treatment was evaluated in 42 HS patients, of which 24 had previously failed anti-tumor necrosis factor (TNF) therapy.
Treatment of Hidradenitis Suppurativa with SAPHO Syndrome: A Case Review
The male patient presented in 2009 with a “3-year history of multiple interconnecting comedones in the axilla and inguinal regions, as well as scarring from previous lesions.”
Hidradenitis Suppurativa: Pharmacological and Surgical Txs Reviewed
The authors reported significant disability and comorbidities among patients with HS, including obesity, metabolic syndrome, diabetes, and arthritis.
Certain Skin Conditions Linked to Greater Reduction in Quality of Life
Highest risk for reduction in HRQoL for hidradenitis suppurativa, blistering conditions, psoriasis
